1. Home
  2. BSX vs GRNQ Comparison

BSX vs GRNQ Comparison

Compare BSX & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • GRNQ
  • Stock Information
  • Founded
  • BSX 1979
  • GRNQ 2013
  • Country
  • BSX United States
  • GRNQ Malaysia
  • Employees
  • BSX N/A
  • GRNQ N/A
  • Industry
  • BSX Medical/Dental Instruments
  • GRNQ EDP Services
  • Sector
  • BSX Health Care
  • GRNQ Technology
  • Exchange
  • BSX Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • BSX 138.5B
  • GRNQ 6.8M
  • IPO Year
  • BSX 1992
  • GRNQ 2018
  • Fundamental
  • Price
  • BSX $101.15
  • GRNQ $0.91
  • Analyst Decision
  • BSX Strong Buy
  • GRNQ
  • Analyst Count
  • BSX 23
  • GRNQ 0
  • Target Price
  • BSX $110.26
  • GRNQ N/A
  • AVG Volume (30 Days)
  • BSX 10.6M
  • GRNQ 11.1K
  • Earning Date
  • BSX 04-23-2025
  • GRNQ 04-09-2025
  • Dividend Yield
  • BSX N/A
  • GRNQ N/A
  • EPS Growth
  • BSX 15.23
  • GRNQ N/A
  • EPS
  • BSX 1.37
  • GRNQ N/A
  • Revenue
  • BSX $17,554,000,000.00
  • GRNQ $3,496,405.00
  • Revenue This Year
  • BSX $15.77
  • GRNQ N/A
  • Revenue Next Year
  • BSX $10.33
  • GRNQ N/A
  • P/E Ratio
  • BSX $73.80
  • GRNQ N/A
  • Revenue Growth
  • BSX 19.36
  • GRNQ 0.54
  • 52 Week Low
  • BSX $70.97
  • GRNQ $0.80
  • 52 Week High
  • BSX $107.17
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • BSX 58.48
  • GRNQ 48.55
  • Support Level
  • BSX $92.70
  • GRNQ $0.87
  • Resistance Level
  • BSX $102.37
  • GRNQ $0.95
  • Average True Range (ATR)
  • BSX 4.08
  • GRNQ 0.04
  • MACD
  • BSX 0.75
  • GRNQ 0.01
  • Stochastic Oscillator
  • BSX 92.53
  • GRNQ 55.56

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: